تقرير
Onset of eosinophilic granulomatosis with polyangiitis (EGPA) after anti-Th2 biotherapy initiation in severe asthma patients: Report of 3 cases.
| العنوان: | Onset of eosinophilic granulomatosis with polyangiitis (EGPA) after anti-Th2 biotherapy initiation in severe asthma patients: Report of 3 cases. |
|---|---|
| المؤلفون: | Fargeas M; Pneumology Department, Hôpital de la Croix-Rousse, Hospices civils de Lyon, Université Claude Bernard, Lyon et CRISALIS / F-CRIN INSERM Network, France., Devouassoux G; Pneumology Department, Hôpital de la Croix-Rousse, Hospices civils de Lyon, Université Claude Bernard, Lyon et CRISALIS / F-CRIN INSERM Network, France. Electronic address: gilles.devouassoux@chu-lyon.fr., Gerfaud-Valentin M; Internal Medicine Department, Hôpital de la Croix-Rousse, Hospices civils de Lyon, France. |
| المصدر: | Respiratory medicine and research [Respir Med Res] 2024 Jun; Vol. 85, pp. 101070. Date of Electronic Publication: 2023 Nov 30. |
| نوع المنشور: | Case Reports; Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Masson SAS Country of Publication: France NLM ID: 101746324 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2590-0412 (Electronic) Linking ISSN: 25900412 NLM ISO Abbreviation: Respir Med Res Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [Issy-les-Moulineaux] : Elsevier Masson SAS, [2019]- |
| مواضيع طبية MeSH: | Asthma*/drug therapy , Asthma*/therapy , Granulomatosis with Polyangiitis*/complications , Granulomatosis with Polyangiitis*/diagnosis , Granulomatosis with Polyangiitis*/drug therapy , Granulomatosis with Polyangiitis*/therapy, Humans ; Female ; Male ; Middle Aged ; Th2 Cells/immunology ; Severity of Illness Index ; Churg-Strauss Syndrome/diagnosis ; Churg-Strauss Syndrome/complications ; Adult ; Anti-Asthmatic Agents/therapeutic use ; Anti-Asthmatic Agents/administration & dosage |
| مستخلص: | Competing Interests: Declaration of Competing Interest GD declare to be consultant for ALK, Astra-Zeneca, Boehringer Ingelheim, Chiesi, GSK, Menarini, Mundi Pharma, Novartis Pharma, Roche, Sanofi, Vivisol, to participate to medical meeting for AGIR adom, ALK, Astra-Zeneca, Boehringer Ingelheim, Chiesi, CIPLA, GSK, Meda, MSD, Novartis Pharma, Orkyn, SANOFI, Takeda, TEVA, to be investigators of clinical assays for AB Science, ALK, Amgen, Astra Zeneca, Boehringer-Ingelheim, Genentech, Gossamer, GSK, Lilly, Novartis Pharma, Regeneron, Roche, SANOFI, TEVA, Vitalair, Zambon to bet research fundings from Agir adom, ALLP, Chiesi, GSK, MSD, Novartis Pharma, Orkyn, Takeda, Vivisol. MGV declare to be consultant for Sobi, Novartis and Amgen. |
| فهرسة مساهمة: | Keywords: Benralizumab; Dupilumab; EGPA; Eosinophilic granulomatosis with polyangiitis; Mepolizumab; Severe asthma |
| المشرفين على المادة: | 0 (Anti-Asthmatic Agents) |
| تواريخ الأحداث: | Date Created: 20231223 Date Completed: 20240614 Latest Revision: 20240624 |
| رمز التحديث: | 20240625 |
| DOI: | 10.1016/j.resmer.2023.101070 |
| PMID: | 38141578 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2590-0412 |
|---|---|
| DOI: | 10.1016/j.resmer.2023.101070 |